Behavioral genetic contributions to the study of addiction-related amphetamine effects

Neuroscience and Biobehavioral Reviews

Volumn 32, Issue 4, 2008, Pages 707-759

  Phillips, Tamara J ^a,b,c   Kamens, Helen M ^b,c   Wheeler, Jeanna M ^b,c  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Amphetamine; Dopamine; Genetics; Glutamate; Inbred strains; MDMA; Methamphetamine; Methylphenidate; Mice; QTL mapping; Selected lines

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; AMPHETAMINE; COCAINE; DEXAMPHETAMINE; DIZOCILPINE; DOPAMINE; DOPAMINE RECEPTOR; ETICLOPRIDE; FLUOXETINE; GLUTAMIC ACID; GLYCINE; HALOPERIDOL; METHAMPHETAMINE; METHYLPHENIDATE; MORPHINE; NALOXONE;

ADDICTION; ATTENTION DEFICIT DISORDER; DRUG MEGADOSE; GENE MAPPING; GENETIC DIFFERENCE; HUMAN; HYPERTHERMIA; INBRED STRAIN; LOCOMOTION; NEUROTOXICITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; REVIEW; REWARD; SOCIAL BEHAVIOR; STEREOTYPY; SUBSTANCE ABUSE; WITHDRAWAL SYNDROME;

AMPHETAMINE; AMPHETAMINE-RELATED DISORDERS; ANIMALS; BEHAVIOR, ADDICTIVE; BEHAVIOR, ANIMAL; CHROMOSOME MAPPING; GENETICS, BEHAVIORAL; HUMANS; MICE; MICE, TRANSGENIC; MUTATION; QUANTITATIVE TRAIT, HERITABLE;

EID: 40149099128     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2007.10.008     Document Type: Review

References (314)

1. Abeliovich A., Schmitz Y., Farinas I., Choi-Lundberg D., Ho W.H., Castillo P.E., Shinsky N., Verdugo J.M., Armanini M., Ryan A., Hynes M., Phillips H., Sulzer D., and Rosenthal A. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25 (2000) 239-252
2. Alexander R.C., Wright R., and Freed W. Quantitative trait loci contributing to phencyclidine-induced and amphetamine-induced locomotor behavior in inbred mice. Neuropsychopharmacology 15 (1996) 484-490
3. Alttoa A., and Harro J. Effect of CCK1 and CCK2 receptor blockade on amphetamine-stimulated exploratory behavior and sensitization to amphetamine. European Neuropsychopharmacology 14 (2004) 324-331
4. Anglin M.D., Burke C., Perrochet B., Stamper E., and Dawud-Noursi S. History of the methamphetamine problem. Journal of Psychoactive Drugs 32 (2000) 137-141
5. Anisman H., Wahlsten D., and Kokkinidis L. Effects of d-amphetamine and scopolamine on activity before and after shock in three mouse strains. Pharmacology, Biochemistry and Behavior 3 (1975) 819-824
6. Atkins A.L., Helms M.L., O'Toole L.A., and Belknap J.K. Stereotypic behaviors in mice selectively bred for high and low methamphetamine-induced stereotypic chewing. Psychopharmacology (Berlin) 157 (2001) 96-104
7. Auclair A., Cotecchia S., Glowinski J., and Tassin J.P. D-amphetamine fails to increase extracellular dopamine levels in mice lacking alpha 1b-adrenergic receptors: relationship between functional and nonfunctional dopamine release. Journal of Neuroscience 22 (2002) 9150-9154
8. Auclair A., Drouin C., Cotecchia S., Glowinski J., and Tassin J.P. 5-HT2A and alpha1b-adrenergic receptors entirely mediate dopamine release, locomotor response and behavioural sensitization to opiates and psychostimulants. European Journal of Neuroscience 20 (2004) 3073-3084
9. Backman C., You Z.B., Perlmann T., and Hoffer B.J. Elevated locomotor activity without altered striatal dopamine contents in Nurr1 heterozygous mice after acute exposure to methamphetamine. Behavioural Brain Research 143 (2003) 95-100
10. Badiani A., Cabib S., and Puglisi-Allegra S. Chronic stress induces strain-dependent sensitization to the behavioral effects of amphetamine in the mouse. Pharmacology, Biochemistry and Behavior 43 (1992) 53-60
11. Ball K.T., Budreau D., and Rebec G.V. Acute effects of 3,4-methylenedioxymethamphetamine on striatal single-unit activity and behavior in freely moving rats: differential involvement of dopamine D(1) and D(2) receptors. Brain Research 994 (2003) 203-215
12. Bartlett E., Hallin A., Chapman B., and Angrist B. Selective sensitization to the psychosis-inducing effects of cocaine: a possible marker for addiction relapse vulnerability?. Neuropsychopharmacology 16 (1997) 77-82
13. Bastia E., Xu Y.H., Scibelli A.C., Day Y.J., Linden J., Chen J.F., and Schwarzschild M.A. A crucial role for forebrain adenosine A(2A) receptors in amphetamine sensitization. Neuropsychopharmacology 30 (2005) 891-900
14. Battaglia G., Fornai F., Busceti C.L., Lembo G., Nicoletti F., and De Blasi A. Alpha-1B adrenergic receptor knockout mice are protected against methamphetamine toxicity. Journal of Neurochemistry 86 (2003) 413-421
15. Beaulieu J.M., Sotnikova T.D., Yao W.D., Kockeritz L., Woodgett J.R., Gainetdinov R.R., and Caron M.G. Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proceedings of the National Academy of Sciences of the United States of America 101 (2004) 5099-5104
16. Beaulieu J.M., Sotnikova T.D., Marion S., Lefkowitz R.J., Gainetdinov R.R., and Caron M.G. An Akt/β-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 122 (2005) 261-273
17. Belknap J.K., and Crabbe J.C. Chromosome mapping of gene loci affecting morphine and amphetamine responses in BXD recombinant inbred mice. Annals of the New York Academy of Sciences 654 (1992) 311-323
18. Belknap J.K., Richards S.P., O'Toole L.A., Helms M.L., and Phillips T.J. Short-term selective breeding as a tool for QTL mapping: ethanol preference drinking in mice. Behavior Genetics 27 (1997) 55-66
19. Belknap J.K., Hitzemann R., Crabbe J.C., Phillips T.J., Buck K.J., and Williams R.W. QTL analysis and genomewide mutagenesis in mice: complementary genetic approaches to the dissection of complex traits. Behavior Genetics 31 (2001) 5-15
20. Bengel D., Murphy D.L., Andrews A.M., Wichems C.H., Feltner D., Heils A., Mossner R., Westphal H., and Lesch K.P. Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice. Molecular Pharmacology 53 (1998) 649-655
21. Bergstrom H.C., Palmer A.A., Wood R.D., Burkhart-Kasch S., McKinnon C.S., and Phillips T.J. Reverse selection for differential response to the locomotor stimulant effects of ethanol provides evidence for pleiotropic genetic influence on locomotor response to other drugs of abuse. Alcoholism: Clinical and Experimental Research 27 (2003) 1535-1547
22. Biala G., Betancur C., Mansuy I.M., and Giros B. The reinforcing effects of chronic D-amphetamine and morphine are impaired in a line of memory-deficient mice overexpressing calcineurin. European Journal of Neuroscience 21 (2005) 3089-3096
23. Blanc G., Trovero F., Vezina P., Herve D., Godeheu A.M., Glowinski J., and Tassin J.P. Blockade of prefronto-cortical alpha 1-adrenergic receptors prevents locomotor hyperactivity induced by subcortical D-amphetamine injection. European Journal of Neuroscience 6 (1994) 293-298
24. Borgkvist A., Puelles E., Carta M., Acampora D., Ang S.L., Wurst W., Goiny M., Fisone G., Simeone A., and Usiello A. Altered dopaminergic innervation and amphetamine response in adult Otx2 conditional mutant mice. Molecular and Cellular Neuroscience 31 (2006) 293-302
25. Borowsky B., Adham N., Jones K.A., Raddatz R., Artymyshyn R., Ogozalek K.L., Durkin M.M., Lakhlani P.P., Bonini J.A., Pathirana S., Boyle N., Pu X., Kouranova E., Lichtblau H., Ochoa F.Y., Branchek T.A., and Gerald C. Trace amines: identification of a family of mammalian G protein-coupled receptors. Proceedings of the National Academy of Sciences of the United States of America 98 (2001) 8966-8971
26. Braff D.L., Swerdlow N.R., and Geyer M.A. Gating and habituation deficits in the schizophrenia disorders. Clinical Neuroscience 3 (1995) 131-139
27. Brandon E.P., Logue S.F., Adams M.R., Qi M., Sullivan S.P., Matsumoto A.M., Dorsa D.M., Wehner J.M., McKnight G.S., and Idzerda R.L. Defective motor behavior and neural gene expression in RIIbeta-protein kinase A mutant mice. Journal of Neuroscience 18 (1998) 3639-3649
28. Bronsert M.R., Mead A.N., Hen R., and Rocha B.A. Amphetamine-induced locomotor activation in 5-HT(1B) knockout mice: effects of injection route on acute and sensitized responses. Behavioural Pharmacology 12 (2001) 549-555
29. Brun P., Begou M., Andrieux A., Mouly-Badina L., Clerget M., Schweitzer A., Scarna H., Renaud B., Job D., and Suaud-Chagny M.F. Dopaminergic transmission in STOP null mice. Journal of Neurochemistry 94 (2005) 63-73
30. Bubar M.J., Pack K.M., Frankel P.S., and Cunningham K.A. Effects of dopamine D1- or D2-like receptor antagonists on the hypermotive and discriminative stimulus effects of (+)-MDMA. Psychopharmacology (Berlin) 173 (2004) 326-336
31. Budygin E.A., Brodie M.S., Sotnikova T.D., Mateo Y., John C.E., Cyr M., Gainetdinov R.R., and Jones S.R. Dissociation of rewarding and dopamine transporter-mediated properties of amphetamine. Proceedings of the National Academy of Sciences of the United States of America 101 (2004) 7781-7786
32. Bunzow J.R., Sonders M.S., Arttamangkul S., Harrison L.M., Zhang G., Quigley D.I., Darland T., Suchland K.L., Pasumamula S., Kennedy J.L., Olson S.B., Magenis R.E., Amara S.G., and Grandy D.K. Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Molecular Pharmacology 60 (2001) 1181-1188
33. Cabib S. Strain-dependent behavioural sensitization to amphetamine: role of environmental influences. Behavioural Pharmacology 4 (1993) 367-374
34. Cabib S., Orsini C., Le Moal M., and Piazza P.V. Abolition and reversal of strain differences in behavioral responses to drugs of abuse after a brief experience. Science 289 (2000) 463-465
35. Cabib S., Ventura R., and Puglisi-Allegra S. Opposite imbalances between mesocortical and mesoaccumbens dopamine responses to stress by the same genotype depending on living conditions. Behavioural Brain Research 129 (2002) 179-185
36. Callaway C.W., Wing L.L., and Geyer M.A. Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats. Journal of Pharmacology and Experimental Therapeutics 254 (1990) 456-464
37. Calzada B.C., and De Artinano A.A. Alpha-adrenoceptor subtypes. Pharmaceutical Research 44 (2001) 195-208
38. Camp D.M., Browman K.E., and Robinson T.E. The effects of methamphetamine and cocaine on motor behavior and extracellular dopamine in the ventral striatum of Lewis versus Fischer 344 rats. Brain Research 668 (1994) 180-193
39. Chen J.F., Beilstein M., Xu Y.H., Turner T.J., Moratalla R., Standaert D.G., Aloyo V.J., Fink J.S., and Schwarzschild M.A. Selective attenuation of psychostimulant-induced behavioral responses in mice lacking A(2A) adenosine receptors. Neuroscience 97 (2000) 195-204
40. Chen J.F., Moratalla R., Impagnatiello F., Grandy D.K., Cuellar B., Rubinstein M., Beilstein M.A., Hackett E., Fink J.S., Low M.J., Ongini E., and Schwarzschild M.A. The role of the D(2) dopamine receptor (D(2)R) in A(2A) adenosine receptor (A(2A)R)-mediated behavioral and cellular responses as revealed by A(2A) and D(2) receptor knockout mice. Proceedings of the National Academy of Sciences of the United States of America 98 (2001) 1970-1975
41. Chen J.F., Fredduzzi S., Bastia E., Yu L., Moratalla R., Ongini E., and Schwarzschild M.A. Adenosine A2A receptors in neuroadaptation to repeated dopaminergic stimulation: implications for the treatment of dyskinesias in Parkinson's disease. Neurology 61 (2003) S74-S81
42. Chen J.F., Moratalla R., Yu L., Martin A.B., Xu K., Bastia E., Hackett E., Alberti I., and Schwarzschild M.A. Inactivation of adenosine A2A receptors selectively attenuates amphetamine-induced behavioral sensitization. Neuropsychopharmacology 28 (2003) 1086-1095
43. Chen P.C., Lao C.L., and Chen J.C. Dual alteration of limbic dopamine D1 receptor-mediated signalling and the Akt/GSK3 pathway in dopamine D3 receptor mutants during the development of methamphetamine sensitization. Journal of Neurochemistry 100 (2007) 225-241
44. Cheon K.A., Ryu Y.H., Kim J.W., and Cho D.Y. The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: relating to treatment response to methylphenidate. European Neuropsychopharmacology 15 (2005) 95-101
45. Choi D.S., Wang D., Dadgar J., Chang W.S., and Messing R.O. Conditional rescue of protein kinase C epsilon regulates ethanol preference and hypnotic sensitivity in adult mice. Journal of Neuroscience 22 (2002) 9905-9911
46. Cirulli F., Adriani W., and Laviola G. Sexual segregation in infant mice: behavioural and neuroendocrine responses to d-amphetamine administration. Psychopharmacology (Berlin) 134 (1997) 140-152
47. Coitinho A.S., Dietrich M.O., Hoffmann A., Dall'Igna O.P., Souza D.O., Martins V.R., Brentani R.R., Izquierdo I., and Lara D.R. Decreased hyperlocomotion induced by MK-801, but not amphetamine and caffeine in mice lacking cellular prion protein (PrP(C)). Brain Research Molecular Brain Research 107 (2002) 190-194
48. Colpaert F.C., Wauquier A., Niemegeers C., and Lal H. Reversal by a central antiacetylcholine drug of pimozide-induced inhibition of mouse-jumping in amphetamine-dopa treated mice. Journal of Pharmacy and Pharmacology 27 (1975) 536-537
49. Cossu G., Ledent C., Fattore L., Imperato A., Bohme G.A., Parmentier M., and Fratta W. Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse. Behavioural Brain Research 118 (2001) 61-65
50. Couceyro P.R., Evans C., McKinzie A., Mitchell D., Dube M., Hagshenas L., White F.J., Douglass J., Richards W.G., and Bannon A.W. Cocaine- and amphetamine-regulated transcript (CART) peptides modulate the locomotor and motivational properties of psychostimulants. Journal of Pharmacology and Experimental Therapeutics 315 (2005) 1091-1100
51. Crabbe J.C. Animal models in neurobehavioral genetics: methods for estimating genetic correlation. In: Mormède P., and Jones B.C. (Eds). Neurobehavioral Genetics: Methods and Applications (1999), CRC Press, Boca Raton, FL 121-138
52. Crabbe J.C., Young E.R., Deutsch C.M., Tam B.R., and Kosobud A. Mice genetically selected for differences in open-field activity after ethanol. Pharmacology, Biochemistry and Behavior 27 (1987) 577-581
53. Crabbe J.C., Phillips T.J., Kosobud A., and Belknap J.K. Estimation of genetic correlation: interpretation of experiments using selectively bred and inbred animals. Alcoholism: Clinical and Experimental Research 14 (1990) 141-151
54. Crabbe J.C., Phillips T.J., Buck K.J., Cunningham C.L., and Belknap J.K. Identifying genes for alcohol and drug sensitivity: recent progress and future directions. Trends in Neuroscience 22 (1999) 173-179
55. Crabbe J.C., Phillips T.J., Harris R.A., Arends M.A., and Koob G.F. Alcohol-related genes: contributions from studies with genetically engineered mice. Addiction Biology 11 (2006) 195-269
56. Crawford C.A., Drago J., Watson J.B., and Levine M.S. Effects of repeated amphetamine treatment on the locomotor activity of the dopamine D1A-deficient mouse. Neuroreport 8 (1997) 2523-2527
57. Crawley J.N. Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesolimbic pathway. Journal of Neuroscience 12 (1992) 3380-3391
58. Cunningham C.L., and Phillips T.J. Genetic basis of ethanol reward. In: Maldonado R. (Ed). Molecular Biology of Drug Addiction (2003), Humana Press, Inc., Totowa, NJ 263-294
59. Cyr M., Morissette M., Barden N., Beaulieu S., Rochford J., and Di Paolo T. Dopaminergic activity in transgenic mice underexpressing glucocorticoid receptors: effect of antidepressants. Neuroscience 102 (2001) 151-158
60. Dai H., Okuda T., Sakurai E., Kuramasu A., Kato M., Jia F., Xu A.J., Iinuma K., Sato I., and Yanai K. Blockage of histamine H1 receptor attenuates social isolation-induced disruption of prepulse inhibition: a study in H1 receptor gene knockout mice. Psychopharmacology (Berlin) 183 (2005) 285-293
61. Davidson C., Gow A.J., Lee T.H., and Ellinwood E.H. Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Research Brain Research Reviews 36 (2001) 1-22
62. Davidson E.S., Finch J.F., and Schenk S. Variability in subjective responses to cocaine: initial experiences of college students. Addictive Behavior 18 (1993) 445-453
63. de Wit H., Uhlenhuth E.H., and Johanson C.E. Individual differences in the reinforcing and subjective effects of amphetamine and diazepam. Drug and Alcohol Dependence 16 (1986) 341-360
64. Del Arco A., Gonzalez-Mora J.L., Armas V.R., and Mora F. Amphetamine increases the extracellular concentration of glutamate in striatum of the awake rat: involvement of high affinity transporter mechanisms. Neuropharmacology 38 (1999) 943-954
65. Del Arco A., Mora F., Mohammed A.H., and Fuxe K. Stimulation of D2 receptors in the prefrontal cortex reduces PCP-induced hyperactivity, acetylcholine release and dopamine metabolism in the nucleus accumbens. Journal of Neural Transmission 114 (2007) 185-193
66. Deutsch S.I., Rosse R.B., Paul S.M., Riggs R.L., and Mastropaolo J. Inbred mouse strains differ in sensitivity to "popping" behavior elicited by MK-801. Pharmacology, Biochemistry and Behavior 57 (1997) 315-317
67. Dluzen D.E., Gao X., Story G.M., Anderson L.I., Kucera J., and Walro J.M. Evaluation of nigrostriatal dopaminergic function in adult +/+ and +/- BDNF mutant mice. Experimental Neurology 170 (2001) 121-128
68. Douglass J., McKinzie A.A., and Couceyro P. PCR differential display identifies a rat brain mRNA that is transcriptionally regulated by cocaine and amphetamine. Journal of Neuroscience 15 (1995) 2471-2481
69. Dracheva S., Xu M., Kelley K.A., Haroutunian V., Holstein G.R., Haun S., Silverstein J.H., and Sealfon S.C. Paradoxical locomotor behavior of dopamine D1 receptor transgenic mice. Experimental Neurology 157 (1999) 169-179
70. Draski L.J., Nash D.J., and Gerhardt G.A. CNS monoamine levels and motoric behaviors in the hotfoot ataxic mutant. Brain Research 645 (1994) 69-77
71. Drouin C., Darracq L., Trovero F., Blanc G., Glowinski J., Cotecchia S., and Tassin J.P. Alpha1b-adrenergic receptors control locomotor and rewarding effects of psychostimulants and opiates. Journal of Neuroscience 22 (2002) 2873-2884
72. Dulawa S.C., Scearce-Levie K.A., Hen R., and Geyer M.A. Serotonin releasers increase prepulse inhibition in serotonin 1B knockout mice. Psychopharmacology (Berlin) 149 (2000) 306-312
73. Eells J.B., Lipska B.K., Yeung S.K., Misler J.A., and Nikodem V.M. Nurr1-null heterozygous mice have reduced mesolimbic and mesocortical dopamine levels and increased stress-induced locomotor activity. Behavioural Brain Research 136 (2002) 267-275
74. Eilam R., Peter Y., Elson A., Rotman G., Shiloh Y., Groner Y., and Segal M. Selective loss of dopaminergic nigro-striatal neurons in brains of Atm-deficient mice. Proceedings of the National Academy of Sciences of the United States of America 95 (1998) 12653-12656
75. Elmer G.I., Pieper J.O., Levy J., Rubinstein M., Low M.J., Grandy D.K., and Wise R.A. Brain stimulation and morphine reward deficits in dopamine D2 receptor-deficient mice. Psychopharmaoclogy 182 (2005) 33-44
76. Eshleman A.J., Carmolli M., Cumbay M., Martens C.R., Neve K.A., and Janowsky A. Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type. Journal of Pharmacology and Experimental Therapeutics 289 (1999) 877-885
77. Falconer D.S., and Mackay T.F.C. Introduction to Quantitative Genetics (1996), Prentice Hall, Essex, England
78. Ferraro T.N., Golden G.T., Smith G.G., Martin J.F., Schwebel C.L., Doyle G.A., Buono R.J., and Berrettini W.H. Confirmation of a major QTL influencing oral morphine intake in C57 and DBA mice using reciprocal congenic strains. Neuropsychopharmacology 30 (2005) 742-746
79. Fetsko L.A., Xu R., and Wang Y. Alterations in D1/D2 synergism may account for enhanced stereotypy and reduced climbing in mice lacking dopamine D2L receptor. Brain Research 967 (2003) 191-200
80. Fleming S.M., Salcedo J., Hutson C.B., Rockenstein E., Masliah E., Levine M.S., and Chesselet M.F. Behavioral effects of dopaminergic agonists in transgenic mice overexpressing human wildtype alpha-synuclein. Neuroscience 142 (2006) 1245-1253
81. Flores C., Manitt C., Rodaros D., Thompson K.M., Rajabi H., Luk K.C., Tritsch N.X., Sadikot A.F., Stewart J., and Kennedy T.E. Netrin receptor deficient mice exhibit functional reorganization of dopaminergic systems and do not sensitize to amphetamine. Molecular Psychiatry 10 (2005) 606-612
82. Florin S.M., Kuczenski R., and Segal D.S. Regional extracellular norepinephrine responses to amphetamine and cocaine and effects of clonidine pretreatment. Brain Research 654 (1994) 53-62
83. Fumagalli F., Gainetdinov R.R., Valenzano K.J., and Caron M.G. Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter. Journal of Neuroscience 18 (1998) 4861-4869
84. Fumagalli F., Gainetdinov R.R., Wang Y.M., Valenzano K.J., Miller G.W., and Caron M.G. Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice. Journal of Neuroscience 19 (1999) 2424-2431
85. Gabbay F.H. Variations in affect following amphetamine and placebo: markers of stimulant drug preference. Experimental and Clinical Psychopharmacology 11 (2003) 91-101
86. Gainetdinov R.R., Wetsel W.C., Jones S.R., Levin E.D., Jaber M., and Caron M.G. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283 (1999) 397-401
87. Gainetdinov R.R., Bohn L.M., Sotnikova T.D., Cyr M., Laakso A., Macrae A.D., Torres G.E., Kim K.M., Lefkowitz R.J., Caron M.G., and Premont R.T. Dopaminergic supersensitivity in G protein-coupled receptor kinase 6-deficient mice. Neuron 38 (2003) 291-303
88. Gaveriaux-Ruff C., and Kieffer B.L. Conditional gene targeting in the mouse nervous system: Insights into brain function and diseases. Pharmacology and Therapeutics 113 (2007) 619-634
89. George F.R., Porrino L.J., Ritz M.C., and Goldberg S.R. Inbred rat strain comparisons indicate different sites of action for cocaine and amphetamine locomotor stimulant effects. Psychopharmacology (Berlin) 104 (1991) 457-462
90. Gerber D.J., Sotnikova T.D., Gainetdinov R.R., Huang S.Y., Caron M.G., and Tonegawa S. Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice. Proceedings of the National Academy of Sciences of the United States of America 98 (2001) 15312-15317
91. Gill K.J., and Boyle A.E. Confirmation of quantitative trait loci for cocaine-induced activation in the AcB/BcA series of recombinant congenic strains. Pharmacogenetics 13 (2003) 329-338
92. Giros B., Jaber M., Jones S.R., Wightman R.M., and Caron M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379 (1996) 606-612
93. Glickstein S.B., and Schmauss C. Effect of methamphetamine on cognition and repetitive motor behavior of mice deficient for dopamine D2 and D3 receptors. Annals of the New York Academy of Sciences 1025 (2004) 110-118
94. Glickstein S.B., and Schmauss C. Focused motor stereotypies do not require enhanced activation of neurons in striosomes. Journal of Comparative Neurology 469 (2004) 227-238
95. Golembiowska K., Konieczny J., Wolfarth S., and Ossowska K. Neuroprotective action of MPEP, a selective mGluR5 antagonist, in methamphetamine-induced dopaminergic neurotoxicity is associated with a decrease in dopamine outflow and inhibition of hyperthermia in rats. Neuropharmacology 45 (2003) 484-492
96. Gora-Maslak G., McClearn G.E., Crabbe J.C., Phillips T.J., Belknap J.K., and Plomin R. Use of recombinant inbred strains to identify quantitative trait loci in psychopharmacology. Psychopharmacology (Berlin) 104 (1991) 413-424
97. Gould T.J., Keith R.A., and Bhat R.V. Differential sensitivity to lithium's reversal of amphetamine-induced open-field activity in two inbred strains of mice. Behavioural Brain Research 118 (2001) 95-105
98. Green A.R., Mechan A.O., Elliott J.M., O'Shea E., and Colado M.I. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacological Reviews 55 (2003) 463-508
99. Greengard P. The neurobiology of slow synaptic transmission. Science 294 (2001) 1024-1030
100. Grisel J.E., Belknap J.K., O'Toole L.A., Helms M.L., Wenger C.D., and Crabbe J.C. Quantitative trait loci affecting methamphetamine responses in BXD recombinant inbred mouse strains. Journal of Neuroscience 17 (1997) 745-754
101. Grupe A., Germer S., Usuka J., Aud D., Belknap J.K., Klein R.F., Ahluwalia M.K., Higuchi R., and Peltz G. In silico mapping of complex disease-related traits in mice. Science 292 (2001) 1915-1918
102. Hahn C.G., Wang H.Y., Cho D.S., Talbot K., Gur R.E., Berrettini W.H., Bakshi K., Kamins J., Borgmann-Winter K.E., Siegel S.J., Gallop R.J., and Arnold S.E. Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nature Medicine 12 (2006) 824-828
103. Hall F.S., Sora I., Drgonova J., Li X.F., Goeb M., and Uhl G.R. Molecular mechanisms underlying the rewarding effects of cocaine. Annals of the New York Academy of Sciences 1025 (2004) 47-56
104. Hamburger-Bar R., Robert M., Newman M., and Belmaker R.H. Interstrain correlation between behavioural effects of lithium and effects on cortical cyclic AMP. Pharmacology, Biochemistry and Behavior 24 (1986) 9-13
105. Han D.D., and Gu H.H. Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs. BMC Pharmacology 6 (2006) 6
106. Hanania T., and Zahniser N.R. Locomotor activity induced by noncompetitive NMDA receptor antagonists versus dopamine transporter inhibitors: opposite strain differences in inbred long-sleep and short-sleep mice. Alcoholism: Clinical and Experimental Research 26 (2002) 431-440
107. Hauser P., Zametkin A.J., Martinez P., Vitiello B., Matochik J.A., Mixson A.J., and Weintraub B.D. Attention deficit-hyperactivity disorder in people with generalized resistance to thyroid hormone. New England Journal of Medicine 328 (1993) 997-1001
108. Heath A.C., Whitfield J.B., Madden P.A., Bucholz K.K., Dinwiddie S.H., Slutske W.S., Bierut L.J., Statham D.B., and Martin N.G. Towards a molecular epidemiology of alcohol dependence: analysing the interplay of genetic and environmental risk factors. British Journal of Psychiatry Suppl. 40 (2001) s33-s40
109. Herve D., Le Moine C., Corvol J.C., Belluscio L., Ledent C., Fienberg A.A., Jaber M., Studler J.M., and Girault J.A. Galpha(olf) levels are regulated by receptor usage and control dopamine and adenosine action in the striatum. Journal of Neuroscience 21 (2001) 4390-4399
110. Hess E.J., Collins K.A., and Wilson M.C. Mouse model of hyperkinesis implicates SNAP-25 in behavioral regulation. Journal of Neuroscience 16 (1996) 3104-3111
111. Heusner C.L., and Palmiter R.D. Expression of mutant NMDA receptors in dopamine D1 receptor-containing cells prevents cocaine sensitization and decreases cocaine preference. Journal of Neuroscience 25 (2005) 6651-6657
112. Himelstein J., Newcorn J.H., and Halperin J.M. The neurobiology of attention-deficit hyperactivity disorder. Frontiers in Bioscience 5 (2000) D461-D478
113. Hokfelt T., Rehfeld J.F., Skirboll L., Ivemark B., Goldstein M., and Markey K. Evidence for coexistence of dopamine and CCK in meso-limbic neurones. Nature 285 (1980) 476-478
114. Holdstock L., King A.C., and de Wit H. Subjective and objective responses to ethanol in moderate/heavy and light social drinkers. Alcoholism: Clinical and Experimental Research 24 (2000) 789-794
115. Holdstock L., and de Wit H. Individual differences in response to ethanol and d-amphetamine: a within-subject study. Alcoholism: Clinical and Experimental Research 25 (2001) 540-548
116. Houchi H., Babovic D., Pierrefiche O., Ledent C., Daoust M., and Naassila M. CB1 receptor knockout mice display reduced ethanol-induced conditioned place preference and increased striatal dopamine D2 receptors. Neuropsychopharmacology 30 (2005) 339-349
117. Huotari M., Garcia-Horsman J.A., Karayiorgou M., Gogos J.A., and Mannisto P.T. D-amphetamine responses in catechol-O-methyltransferase (COMT) disrupted mice. Psychopharmacology (Berlin) 172 (2004) 1-10
118. Ihalainen J.A., Tanila H., Scheinin M., and Riekkinen Jr. P. alpha(2C)-Adrenoceptors modulate the effect of methylphenidate on response rate and discrimination accuracy in an operant test. Brain Research Bulletin 54 (2001) 553-557
119. Ishiguro H., Liu Q.R., Gong J.P., Hall F.S., Ujike H., Morales M., Sakurai T., Grumet M., and Uhl G.R. NrCAM in addiction vulnerability: positional cloning, drug-regulation, haplotype-specific expression, and altered drug reward in knockout mice. Neuropsychopharmacology 31 (2006) 572-584
120. Itier J.M., Ibanez P., Mena M.A., Abbas N., Cohen-Salmon C., Bohme G.A., Laville M., Pratt J., Corti O., Pradier L., Ret G., Joubert C., Periquet M., Araujo F., Negroni J., Casarejos M.J., Canals S., Solano R., Serrano A., Gallego E., Sanchez M., Denefle P., Benavides J., Tremp G., Rooney T.A., Brice A., and Garcia de Yebenes J. Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse. Human and Molecular Genetics 12 (2003) 2277-2291
121. Itzhak Y., and Ali S.F. Behavioral consequences of methamphetamine-induced neurotoxicity in mice: relevance to the psychopathology of methamphetamine addiction. Annals of the New York Academy of Sciences 965 (2002) 127-135
122. Itzhak Y., Gandia C., Huang P.L., and Ali S.F. Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity. Journal of Pharmacology and Experimental Therapeutics 284 (1998) 1040-1047
123. Itzhak Y., Martin J.L., and Ali S.F. Comparison between the role of the neuronal and inducible nitric oxide synthase in methamphetamine-induced neurotoxicity and sensitization. Annals of the New York Academy of Sciences 914 (2000) 104-111
124. Itzhak Y., Anderson K.L., and Ali S.F. Differential response of nNOS knockout mice to MDMA ("ecstasy")- and methamphetamine-induced psychomotor sensitization and neurotoxicity. Annals of the New York Academy of Sciences 1025 (2004) 119-128
125. Iwabuchi K., Kubota Y., Ito C., Watanabe T., Watanabe T., and Yanai K. Methamphetamine and brain histamine: a study using histamine-related gene knockout mice. Annals of the New York Academy of Sciences 1025 (2004) 129-134
126. Jackson A., Mead A.N., and Stephens D.N. Behavioural effects of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate-receptor antagonists and their relevance to substance abuse. Pharmacology and Therapeutics 88 (2000) 59-76
127. Janowsky A., Mah C., Johnson R.A., Cunningham C.L., Phillips T.J., Crabbe J.C., Eshleman A.J., and Belknap J.K. Mapping genes that regulate density of dopamine transporters and correlated behaviors in recombinant inbred mice. Journal of Pharmacology and Experimental Therapeutics 298 (2001) 634-643
128. Jinnah H.A., Gage F.H., and Friedmann T. Amphetamine-induced behavioral phenotype in a hypoxanthine-guanine phosphoribosyltransferase-deficient mouse model of Lesch-Nyhan syndrome. Behavioral Neuroscience 105 (1991) 1004-1012
129. Jinnah H.A., Langlais P.J., and Friedmann T. Functional analysis of brain dopamine systems in a genetic mouse model of Lesch-Nyhan syndrome. Journal of Pharmacology and Experimental Therapeutics 263 (1992) 596-607
130. Jones S., and Bonci A. Synaptic plasticity and drug addiction. Current Opinion in Pharmacology 5 (2005) 20-25
131. Juhila J., Honkanen A., Sallinen J., Haapalinna A., Korpi E.R., and Scheinin M. alpha(2A)-Adrenoceptors regulate d-amphetamine-induced hyperactivity and behavioural sensitization in mice. European Journal of Pharmacology 517 (2005) 74-83
132. Kahlig K.M., Binda F., Khoshbouei H., Blakely R.D., McMahon D.G., Javitch J.A., and Galli A. Amphetamine induces dopamine efflux through a dopamine transporter channel. Proceedings of the National Academy of Sciences of the United States of America 102 (2005) 3495-3500
133. Kalueff A.V., Ren-Patterson R.F., and Murphy D.L. The developing use of heterozygous mutant mouse models in brain monoamine transporter research. Trends in Pharmacology Science 28 (2007) 122-127
134. Kamens H.M., Burkhart-Kasch S., McKinnon C.S., Li N., Reed C., and Phillips T.J. Sensitivity to psychostimulants in mice bred for high and low stimulation to methamphetamine. Genes, Brain and Behavior 4 (2005) 110-125
135. Kamens H.M., Burkhart-Kasch S., McKinnon C.S., Li N., Reed C., and Phillips T.J. Ethanol-related traits in mice selectively bred for differential sensitivity to methamphetamine-induced activation. Behavioral Neuroscience 120 (2006) 1356-1366
136. Karper P.E., De la Rosa H., Newman E.R., Krall C.M., Nazarian A., McDougall S.A., and Crawford C.A. Role of D1-like receptors in amphetamine-induced behavioral sensitization: a study using D1A receptor knockout mice. Psychopharmacology (Berlin) 159 (2002) 407-414
137. Kas M.J., van den Bos R., Baars A.M., Lubbers M., Lesscher H.M., Hillebrand J.J., Schuller A.G., Pintar J.E., and Spruijt B.M. Mu-opioid receptor knockout mice show diminished food-anticipatory activity. European Journal of Neuroscience 20 (2004) 1624-1632
138. Kehne J.H., Ketteler H.J., McCloskey T.C., Sullivan C.K., Dudley M.W., and Schmidt C.J. Effects of the selective 5-HT2A receptor antagonist MDL 100,907 on MDMA-induced locomotor stimulation in rats. Neuropsychopharmacology 15 (1996) 116-124
139. Kest B., Palmese C.A., Hopkins E., Adler M., Juni A., and Mogil J.S. Naloxone-precipitated withdrawal jumping in 11 inbred mouse strains: evidence for common genetic mechanisms in acute and chronic morphine physical dependence. Neuroscience 115 (2002) 463-469
140. Kholodilov N., Yarygina O., Oo T.F., Zhang H., Sulzer D., Dauer W., and Burke R.E. Regulation of the development of mesencephalic dopaminergic systems by the selective expression of glial cell line-derived neurotrophic factor in their targets. Journal of Neuroscience 24 (2004) 3136-3146
141. Kieffer B.L., and Gaveriaux-Ruff C. Exploring the opioid system by gene knockout. Progress in Neurobiology 66 (2002) 285-306
142. Kim R.H., Smith P.D., Aleyasin H., Hayley S., Mount M.P., Pownall S., Wakeham A., You-Ten A.J., Kalia S.K., Horne P., Westaway D., Lozano A.M., Anisman H., Park D.S., and Mak T.W. Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. Proceedings of the National Academy of Sciences of the United States of America 102 (2005) 5215-5220
143. Kimmel H.L., Gong W., Vechia S.D., Hunter R.G., and Kuhar M.J. Intra-ventral tegmental area injection of rat cocaine and amphetamine-regulated transcript peptide 55-102 induces locomotor activity and promotes conditioned place preference. Journal of Pharmacology and Experimental Therapeutics 294 (2000) 784-792
144. King A.C., Houle T., de Wit H., Holdstock L., and Schuster A. Biphasic alcohol response differs in heavy versus light drinkers. Alcoholism: Clinical and Experimental Research 26 (2002) 827-835
145. Kirley A., Lowe N., Hawi Z., Mullins C., Daly G., Waldman I., McCarron M., O'Donnell D., Fitzgerald M., and Gill M. Association of the 480 bp DAT1 allele with methylphenidate response in a sample of Irish children with ADHD. American Journal of Medical Genetics B: Neuropsychiatric Genetics 121 (2003) 50-54
146. Kitahama K., and Valatx J.L. Strain differences in amphetamine sensitivity in mice. I. A diallel analysis of open field activity. Psychopharmacology (Berlin) 66 (1979) 189-194
147. Kliethermes C.L., Kamens H.M., and Crabbe J.C. Drug reward and intake in lines of mice selectively bred for divergent exploration of a hole board apparatus. Genes, Brain and Behavior 6 (2007) 608-618
148. Koks S., Volke V., Veraksits A., Runkorg K., Sillat T., Abramov U., Bourin M., Huotari M., Mannisto P.T., Matsui T., and Vasar E. Cholecystokinin2 receptor-deficient mice display altered function of brain dopaminergic system. Psychopharmacology (Berlin) 158 (2001) 198-204
149. Koks S., Abramov U., Veraksits A., Bourin M., Matsui T., and Vasar E. CCK2 receptor-deficient mice have increased sensitivity of dopamine D2 receptors. Neuropeptides 37 (2003) 25-29
150. Koob G.F., and Le Moal M. Neurobiology of Addiction (2006), Academic Press, San Diego, CA
151. Koshimizu T.A., Tanoue A., Hirasawa A., Yamauchi J., and Tsujimoto G. Recent advances in alpha1-adrenoceptor pharmacology. Pharmacology and Therapeutics 98 (2003) 235-244
152. Kruzich P.J., Suchland K.L., and Grandy D.K. Dopamine D4 receptor-deficient mice, congenic on the C57BL/6J background, are hypersensitive to amphetamine. Synapse 53 (2004) 131-139
153. Kubota Y., Ito C., Sakurai E., Sakurai E., Watanabe T., and Ohtsu H. Increased methamphetamine-induced locomotor activity and behavioral sensitization in histamine-deficient mice. Journal of Neurochemistry 83 (2002) 837-845
154. Kuo D.Y., Inui A., and Cheng J.T. Effect of amphetamine repeated treatment on the feeding behavior in neuropeptide Y-overexpressing mice. Neuroscience Letters 329 (2002) 359-361
155. Kuribara H. Effects of interdose interval on ambulatory sensitization to methamphetamine, cocaine and morphine in mice. European Journal of Pharmacology 316 (1996) 1-5
156. Kurose H., Regan J.W., Caron M.G., and Lefkowitz R.J. Functional interactions of recombinant alpha 2 adrenergic receptor subtypes and G proteins in reconstituted phospholipid vesicles. Biochemistry 30 (1991) 3335-3341
157. Kuteeva E., Hokfelt T., and Ogren S.O. Behavioural characterisation of transgenic mice overexpressing galanin under the PDGF-B promoter. Neuropeptides 39 (2005) 299-304
158. Kuteeva E., Hokfelt T., and Ogren S.O. Behavioural characterisation of young adult transgenic mice overexpressing galanin under the PDGF-B promoter. Regulatory Peptides 125 (2005) 67-78
159. Laakso A., Mohn A.R., Gainetdinov R.R., and Caron M.G. Experimental genetic approaches to addiction. Neuron 36 (2002) 213-228
160. Labarca C., Schwarz J., Deshpande P., Schwarz S., Nowak M.W., Fonck C., Nashmi R., Kofuji P., Dang H., Shi W., Fidan M., Khakh B.S., Chen Z., Bowers B.J., Boulter J., Wehner J.M., and Lester H.A. Point mutant mice with hypersensitive alpha 4 nicotinic receptors show dopaminergic deficits and increased anxiety. Proceedings of the National Academy of Sciences of the United States of America 98 (2001) 2786-2791
161. Lahdesmaki J., Sallinen J., MacDonald E., and Scheinin M. Alpha2A-adrenoceptors are important modulators of the effects of D-amphetamine on startle reactivity and brain monoamines. Neuropsychopharmacology 29 (2004) 1282-1293
162. Lal H., Colpaert F.C., and Laduron P. Narcotic withdrawal like mouse jumping produced by amphetamine and L-DOPA. European Journal of Pharmacology 30 (1975) 113-116
163. Lal H., Marky M., and Fielding S. Effect of neuroleptic drugs on mouse jumping induced by L-DOPA in amphetamine treated mice. Neuropharmacology 15 (1976) 669-671
164. Maldonado E., and Navarro J.F. MDMA ("ecstasy") exhibits an anxiogenic-like activity in social encounters between male mice. Pharmacology Research 44 (2001) 27-31
165. Mao L., Conquet F., and Wang J.Q. Augmented motor activity and reduced striatal preprodynorphin mRNA induction in response to acute amphetamine administration in metabotropic glutamate receptor 1 knockout mice. Neuroscience 106 (2001) 303-312
166. Marazziti D., Golini E., Mandillo S., Magrelli A., Witke W., Matteoni R., and Tocchini-Valentini G.P. Altered dopamine signaling and MPTP resistance in mice lacking the Parkinson's disease-associated GPR37/parkin-associated endothelin-like receptor. Proceedings of the National Academy of Sciences of the United States of America 101 (2004) 10189-10194
167. Marquez P., Baliram R., Kieffer B.L., and Lutfy K. The mu opioid receptor is involved in buprenorphine-induced locomotor stimulation and conditioned place preference. Neuropharmacology 52 (2007) 1336-1341
168. Marley R.J., Arros D.M., Henricks K.K., Marley M.E., and Miner L.L. Sensitivity to cocaine and amphetamine among mice selectively bred for differential cocaine sensitivity. Psychopharmacology (Berlin) 140 (1998) 42-51
169. McCann U.D., Wong D.F., Yokoi F., Villemagne V., Dannals R.F., and Ricaurte G.A. Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428. Journal of Neuroscience 18 (1998) 8417-8422
170. McDougall S.A., Reichel C.M., Cyr M.C., Karper P.E., Nazarian A., and Crawford C.A. Importance of D(1) receptors for associative components of amphetamine-induced behavioral sensitization and conditioned activity: a study using D(1) receptor knockout mice. Psychopharmacology (Berlin) 183 (2005) 20-30
171. McKerchar T.L., Zarcone T.J., and Fowler S.C. Use of a force-plate actometer for detecting and quantifying vertical leaping induced by amphetamine in BALB/cJ mice, but not in C57BL/6J, DBA/2J, 129×1/SvJ, C3H/HeJ, and CD-1 mice. Journal of Neuroscience Methods 153 (2006) 48-54
172. McNamara R.K., Logue A., Stanford K., Xu M., Zhang J., and Richtand N.M. Dose-response analysis of locomotor activity and stereotypy in dopamine D3 receptor mutant mice following acute amphetamine. Synapse 60 (2006) 399-405
173. Mead A.N., and Stephens D.N. Involvement of AMPA receptor GluR2 subunits in stimulus-reward learning: evidence from glutamate receptor gria2 knock-out mice. Journal of Neuroscience 23 (2003) 9500-9507
174. Mick E., Biederman J., Spencer T., Faraone S.V., and Sklar P. Absence of association with DAT1 polymorphism and response to methylphenidate in a sample of adults with ADHD. American Journal of Medical Genetics B: Neuropsychiatric Genetics 141 (2006) 890-894
175. Miserendino M.J., Haile C.N., and Kosten T.A. Strain differences in response to escapable and inescapable novel environments and their ability to predict amphetamine-induced locomotor activity. Psychopharmacology (Berlin) 167 (2003) 281-290
176. Mixson A.J., Parrilla R., Ransom S.C., Wiggs E.A., McClaskey J.H., Hauser P., and Weintraub B.D. Correlations of language abnormalities with localization of mutations in the beta-thyroid hormone receptor in 13 kindreds with generalized resistance to thyroid hormone: identification of four new mutations. Journal of Clinical Endocrinology and Metabolism 75 (1992) 1039-1045
177. Miyamoto S., Snouwaert J.N., Koller B.H., Moy S.S., Lieberman J.A., and Duncan G.E. Amphetamine-induced Fos is reduced in limbic cortical regions but not in the caudate or accumbens in a genetic model of NMDA receptor hypofunction. Neuropsychopharmacology 29 (2004) 2180-2188
178. Miyamoto Y., Yamada K., Nagai T., Mori H., Mishina M., Furukawa H., Noda Y., and Nabeshima T. Behavioural adaptations to addictive drugs in mice lacking the NMDA receptor epsilon1 subunit. European Journal of Neuroscience 19 (2004) 151-158
179. Moffett M., Stanek L., Harley J., Rogge G., Asnicar M., Hsiung H., and Kuhar M. Studies of cocaine- and amphetamine-regulated transcript (CART) knockout mice. Peptides 27 (2006) 2037-2045
180. Mogenson G.J., Jones D.L., and Yim C.Y. From motivation to action: functional interface between the limbic system and the motor system. Progress in Neurobiology 14 (1980) 69-97
181. Mohammed A.K., Danysz W., Ogren S.O., and Archer T. Central noradrenaline depletion attenuates amphetamine-induced locomotor behavior. Neuroscience Letters 64 (1986) 139-144
182. Moisset B. Genetic analysis of the behavioral response to d-amphetamine in mice. Psychopharmacology (Berlin) 53 (1977) 269-276
183. Moisset B., and Welch B.L. Effects of d-amphetamine upon open field behaviour in two inbred strains of mice. Experientia 29 (1973) 625-626
184. Mori A., Okuyama K., Horie M., Taniguchi Y., Wadatsu T., Nishino N., Shimada Y., Miyazawa N., Takeda S., Niimi M., Kyushiki H., Kondo M., and Mitsumoto Y. Alteration of methamphetamine-induced striatal dopamine release in mint-1 knockout mice. Neuroscience Research 43 (2002) 251-257
185. Morio A., Ujike H., Nomura A., Tanaka Y., Morita Y., Otani K., Kishimoto M., Harano M., Inada T., Komiyama T., Yamada M., Sekine Y., Iwata N., Iyo M., Sora I., Ozaki N., and Kuroda S. No association between CART (cocaine- and amphetamine-regulated transcript) gene and methamphetamine dependence. Annals of the New York Academy of Sciences 1074 (2006) 411-417
186. Mueller K., Saboda S., Palmour R., and Nyhan W.L. Self-injurious behavior produced in rats by daily caffeine and continuous amphetamine. Pharmacology, Biochemistry and Behavior 17 (1982) 613-617
187. Nabeshima T., Itoh A., Kobayashi K., Morita S., Mizuguchi T., Sawada H., Nitta A., Hasegawa T., Hayashi K., and Nagatsu T. Effects of subacute administration of methamphetamine and nicotine on locomotor activity in transgenic mice expressing the human tyrosine hydroxylase gene. Journal of Neural Transmission Genetics Section 97 (1994) 41-49
188. Nadeau J.H., and Frankel W.N. The roads from phenotypic variation to gene discovery: mutagenesis versus QTLs. Nature Genetics 25 (2000) 381-384
189. Nagai T., Noda Y., Ishikawa K., Miyamoto Y., Yoshimura M., Ito M., Takayanagi M., Takuma K., Yamada K., and Nabeshima T. The role of tissue plasminogen activator in methamphetamine-related reward and sensitization. Journal of Neurochemistry 92 (2005) 660-667
190. Nakajima A., Yamada K., Nagai T., Uchiyama T., Miyamoto Y., Mamiya T., He J., Nitta A., Mizuno M., Tran M.H., Seto A., Yoshimura M., Kitaichi K., Hasegawa T., Saito K., Yamada Y., Seishima M., Sekikawa K., Kim H.C., and Nabeshima T. Role of tumor necrosis factor-alpha in methamphetamine-induced drug dependence and neurotoxicity. Journal of Neuroscience 24 (2004) 2212-2225
191. Newlin D.B., and Thomson J.B. Chronic tolerance and sensitization to alcohol in sons of alcoholics: II. Replication and reanalysis. Experimental and Clinical Psychopharmacology 7 (1999) 234-243
192. Nishii K., Matsushita N., Sawada H., Sano H., Noda Y., Mamiya T., Nabeshima T., Nagatsu I., Hata T., Kiuchi K., Yoshizato H., Nakashima K., Nagatsu T., and Kobayashi K. Motor and learning dysfunction during postnatal development in mice defective in dopamine neuronal transmission. Journal of Neuroscience Research 54 (1998) 450-464
193. Numachi Y., Ohara A., Yamashita M., Fukushima S., Kobayashi H., Hata H., Watanabe H., Hall F.S., Lesch K.P., Murphy D.L., Uhl G.R., and Sora I. Methamphetamine-induced hyperthermia and lethal toxicity: Role of the dopamine and serotonin transporters. European Journal of Pharmacology (2007) 10.1016/j.ejphar.2007.06.022
194. Okabe C., Takeshima H., and Murphy N.P. Methamphetamine sensitization in nociceptin receptor knockout mice: locomotor and c-fos expression. European Journal of Pharmacology 507 (2005) 57-67
195. Oliverio A., Eleftheriou B.E., and Bailey D.W. Exploratory activity: genetic analysis of its modification by scopolamine and amphetamine. Physiology and Behavior 10 (1973) 893-899
196. Orb S., Wieacker J., Labarca C., Fonck C., Lester H.A., and Schwarz J. Knockin mice with Leu9'Ser alpha4-nicotinic receptors: substantia nigra dopaminergic neurons are hypersensitive to agonist and lost postnatally. Physiology and Genomics 18 (2004) 299-307
197. Orsini C., Buchini F., Piazza P.V., Puglisi-Allegra S., and Cabib S. Susceptibility to amphetamine-induced place preference is predicted by locomotor response to novelty and amphetamine in the mouse. Psychopharmacology (Berlin) 172 (2004) 264-270
198. Palmer A.A., and Phillips T.J. Quantitative trait locus (QTL) mapping in mice. In: Yuan L., and Lovinger D.M. (Eds). Methods in Alcohol-Related Neuroscience Research (2000), CRC Press, Boca Raton, FL 1-30
199. Palmer A.A., Verbitsky M., Suresh R., Kamens H.M., Reed C.L., Li N., Burkhart-Kasch S., McKinnon C.S., Belknap J.K., Gilliam T.C., and Phillips T.J. Gene expression differences in mice divergently selected for methamphetamine sensitivity. Mammalian Genome 16 (2005) 291-305
200. Pettit H.O., and Mueller K. Infusions of cholecystokinin octapeptide into the ventral tegmental area potentiate amphetamine-conditioned place preferences. Psychopharmacology (Berlin) 99 (1989) 423-426
201. Perez F.A., Curtis W.R., and Palmiter R.D. Parkin-deficient mice are not more sensitive to 6-hydroxydopamine or methamphetamine neurotoxicity. BMC Neuroscience 24 (2005) 71
202. Phillips T.J., and Shen E.H. Neurochemical bases of locomotion and ethanol stimulant effects. International Review of Neurobiology 39 (1996) 243-282
203. Phillips T.J., and Belknap J.K. Complex-trait genetics: emergence of multivariate strategies. Nature Reviews Neuroscience 3 (2002) 478-485
204. Phillips T.J., Burkhart-Kasch S., Terdal E.S., and Crabbe J.C. Response to selection for ethanol-induced locomotor activation: genetic analyses and selection response characterization. Psychopharmacology (Berlin) 103 (1991) 557-566
205. Phillips T.J., Burkhart-Kasch S., Gwiazdon C.C., and Crabbe J.C. Locomotor responses of FAST and SLOW mice to several alcohols and drugs of abuse. Annals of the New York Academy of Sciences 654 (1992) 499-501
206. Phillips T.J., Dickinson S., and Burkhart-Kasch S. Behavioral sensitization to drug stimulant effects in C57BL/6J and DBA/2J inbred mice. Behavioural Neuroscience 108 (1994) 789-803
207. Phillips T.J., Hen R., and Crabbe J.C. Complications associated with genetic background effects in research using knockout mice. Psychopharmacology (Berlin) 147 (1999) 5-7
208. Phillips T.J., Belknap J.K., Hitzemann R.J., Buck K.J., Cunningham C.L., and Crabbe J.C. Harnessing the mouse to unravel the genetics of human disease. Genes, Brain and Behavior 1 (2002) 14-26
209. Phillips T.J., Shen E.H., McKinnon C.S., Burkhart-Kasch S., Lessov C.N., and Palmer A.A. Forward, relaxed, and reverse selection for reduced and enhanced sensitivity to ethanol's locomotor stimulant effects in mice. Alcoholism: Clinical and Experimental Research 26 (2002) 593-602
210. Piazza P.V., Deminiere J.M., Le Moal M., and Simon H. Factors that predict individual vulnerability to amphetamine self-administration. Science 245 (1989) 1511-1513
211. Piazza P.V., Deminiere J.M., Maccari S., Mormede P., Le Moal M., and Simon H. Individual reactivity to novelty predicts probability of amphetamine self-administration. Behavioural Pharmacology 1 (1990) 339-345
212. Pillai-Nair N., Panicker A.K., Rodriguiz R.M., Gilmore K.L., Demyanenko G.P., Huang J.Z., Wetsel W.C., and Maness P.F. Neural cell adhesion molecule-secreting transgenic mice display abnormalities in GABAergic interneurons and alterations in behavior. Journal of Neuroscience 25 (2005) 4659-4671
213. Pineda J.R., Canals J.M., Bosch M., Adell A., Mengod G., Artigas F., Ernfors P., and Alberch J. Brain-derived neurotrophic factor modulates dopaminergic deficits in a transgenic mouse model of Huntington's disease. Journal of Neurochemistry 93 (2005) 1057-1068
214. Poikolainen K. Risk factors for alcohol dependence: a case-control study. Alcohol and Alcoholism 35 (2000) 190-196
215. Powell S.B., Lehmann-Masten V.D., Paulus M.P., Gainetdinov R.R., Caron M.G., and Geyer M.A. MDMA "ecstasy" alters hyperactive and perseverative behaviors in dopamine transporter knockout mice. Psychopharmacology (Berlin) 173 (2004) 310-317
216. Ralph R.J., Varty G.B., Kelly M.A., Wang Y.M., Caron M.G., Rubinstein M., Grandy D.K., Low M.J., and Geyer M.A. The dopamine D2, but not D3 or D4, receptor subtype is essential for the disruption of prepulse inhibition produced by amphetamine in mice. Journal of Neuroscience 19 (1999) 4627-4633
217. Ralph R.J., Paulus M.P., and Geyer M.A. Strain-specific effects of amphetamine on prepulse inhibition and patterns of locomotor behavior in mice. Journal of Pharmacology and Experimental Therapeutics 298 (2001) 148-155
218. Ralph-Williams R.J., Lehmann-Masten V., Otero-Corchon V., Low M.J., and Geyer M.A. Differential effects of direct and indirect dopamine agonists on prepulse inhibition: a study in D1 and D2 receptor knock-out mice. Journal of Neuroscience 22 (2002) 9604-9611
219. Reed T.M., Repaske D.R., Snyder G.L., Greengard P., and Vorhees C.V. Phosphodiesterase 1B knock-out mice exhibit exaggerated locomotor hyperactivity and DARPP-32 phosphorylation in response to dopamine agonists and display impaired spatial learning. Journal of Neuroscience 22 (2002) 5188-5197
220. Remington G., and Anisman H. Genetic and ontogenetic variations in locomotor activity following treatment with scopolamine or d-amphetamine. Developmental Psychobiology 9 (1976) 579-585
221. Resnick A., Homanics G.E., Jung B.J., and Peris J. Increased acute cocaine sensitivity and decreased cocaine sensitization in GABA(A) receptor beta3 subunit knockout mice. Journal of Neurochemistry 73 (1999) 1539-1548
222. Reynolds D.S., O'Meara G.F., Newman R.J., Bromidge F.A., Atack J.R., Whiting P.J., Rosahl T.W., and Dawson G.R. GABA(A) alpha 1 subunit knock-out mice do not show a hyperlocomotor response following amphetamine or cocaine treatment. Neuropharmacology 44 (2003) 190-198
223. Richfield E.K., Thiruchelvam M.J., Cory-Slechta D.A., Wuertzer C., Gainetdinov R.R., Caron M.G., Di Monte D.A., and Federoff H.J. Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice. Experimenral Neurology 175 (2002) 35-48
224. Riddle E.L., Fleckenstein A.E., and Hanson G.R. Mechanisms of methamphetamine-induced dopaminergic neurotoxicity. AAPS Journal 8 (2006) E413-E418
225. Risbrough V.B., Masten V.L., Caldwell S., Paulus M.P., Low M.J., and Geyer M.A. Differential contributions of dopamine D1, D2, and D3 receptors to MDMA-induced effects on locomotor behavior patterns in mice. Neuropsychopharmacology 31 (2006) 2349-2358
226. Robinson T.E. Behavioral sensitization: characterization of enduring changes in rotational behavior produced by intermittent injections of amphetamine in male and female rats. Psychopharmacology (Berlin) 84 (1984) 466-475
227. Robinson T.E., and Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Research Brain Research Review 18 (1993) 247-291
228. Robinson T.E., Becker J.B., and Presty S.K. Long-term facilitation of amphetamine-induced rotational behavior and striatal dopamine release produced by a single exposure to amphetamine: sex differences. Brain Research 253 (1982) 231-241
229. Robledo P., Mendizabal V., Ortuno J., de la Torre R., Kieffer B.L., and Maldonado R. The rewarding properties of MDMA are preserved in mice lacking mu-opioid receptors. European Journal of Neuroscience 20 (2004) 853-858
230. Roman T., Szobot C., Martins S., Biederman J., Rohde L.A., and Hutz M.H. Dopamine transporter gene and response to methylphenidate in attention-deficit/hyperactivity disorder. Pharmacogenetics 12 (2002) 497-499
231. Ron D., and Jurd R. The "ups and downs" of signaling cascades in addiction. Science's STKE (2005) 2005, re14
232. Rothman R.B., and Baumann M.H. Monoamine transporters and psychostimulant drugs. European Journal of Pharmacology 479 (2003) 23-40
233. Rothman R.B., Baumann M.H., Dersch C.M., Romero D.V., Rice K.C., Carroll F.I., and Partilla J.S. Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 39 (2001) 32-41
234. Rubinstein M., Phillips T.J., Bunzow J.R., Falzone T.L., Dziewczapolski G., Zhang G., Fang Y., Larson J.L., McDougall J.A., Chester J.A., Saez C., Pugsley T.A., Gershanik O., Low M.J., and Grandy D.K. Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine. Cell 90 (1997) 991-1001
235. Runkorg K., Varv S., Matsui T., Koks S., and Vasar E. Differences in behavioural effects of amphetamine and dopamine-related gene expression in wild-type and homozygous CCK(2) receptor deficient mice. Neuroscience Letters 406 (2006) 17-22
236. Sadalge A., Coughlin L., Fu H., Wang B., Valladares O., Valentino R., and Blendy J.A. alpha 1d Adrenoceptor signaling is required for stimulus induced locomotor activity. Molecular Psychiatry 8 (2003) 664-672
237. Sallinen J., Haapalinna A., Viitamaa T., Kobilka B.K., and Scheinin M. D-amphetamine and L-5-hydroxytryptophan-induced behaviours in mice with genetically altered expression of the alpha2C-adrenergic receptor subtype. Neuroscience 86 (1998) 959-965
238. Scearce-Levie K., Chen J.P., Gardner E., and Hen R. 5-HT receptor knockout mice: pharmacological tools or models of psychiatric disorders. Annals of the New York Academy of Sciences 868 (1999) 701-715
239. Scearce-Levie K., Viswanathan S.S., and Hen R. Locomotor response to MDMA is attenuated in knockout mice lacking the 5-HT1B receptor. Psychopharmacology (Berlin) 141 (1999) 154-161
240. Schiorring E. Psychopathology induced by "speed drugs". Pharmacology, Biochemistry and Behavior 14 Suppl. 1 (1981) 109-122
241. Schmidt C.J., Ritter J.K., Sonsalla P.K., Hanson G.R., and Gibb J.W. Role of dopamine in the neurotoxic effects of methamphetamine. Journal of Pharmacology and Experimental Therapeutics 233 (1985) 539-544
242. Schuckit M.A., and Smith T.L. The relationships of a family history of alcohol dependence, a low level of response to alcohol and six domains of life functioning to the development of alcohol use disorders. Journal of Studies on Alcohol 61 (2000) 827-835
243. Schuckit M.A., and Smith T.L. The clinical course of alcohol dependence associated with a low level of response to alcohol. Addiction 96 (2001) 903-910
244. Seale T.W., Carney J.M., Johnson P., and Rennert O.M. Inheritance of amphetamine-induced thermoregulatory responses in inbred mice. Pharmacology, Biochemistry and Behavior 23 (1985) 373-377
245. Seeman P., Ko F., and Tallerico T. Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics. Molecular Psychiatry 10 (2005) 877-883
246. Segal D.S., Geyer M.A., and Weiner B.E. Strain differences during intraventricular infusion of norepinephrine: possible role of receptor sensitivity. Science 189 (1975) 301-303
247. Segal D.S., Kuczenski R., O'Neil M.L., Melega W.P., and Cho A.K. Prolonged exposure of rats to intravenous methamphetamine: behavioral and neurochemical characterization. Psychopharmacology (Berlin) 180 (2005) 501-512
248. Sekine Y., Minabe Y., Ouchi Y., Takei N., Iyo M., Nakamura K., Suzuki K., Tsukada H., Okada H., Yoshikawa E., Futatsubashi M., and Mori N. Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms. American Journal of Psychiatry 160 (2003) 1699-1701
249. Seong E., Saunders T.L., Stewart C.L., and Burmeister M. To knockout in 129 or in C57BL/6: that is the question. Trends in Genetics 20 (2004) 59-62
250. Shaldubina A., Buccafusca R., Johanson R.A., Agam G., Belmaker R.H., Berry G.T., and Bersudsky Y. Behavioural phenotyping of sodium-myo-inositol cotransporter heterozygous knockout mice with reduced brain inositol. Genes, Brain and Behavior 6 (2007) 253-259
251. Shen E.H., Harland R.D., Crabbe J.C., and Phillips T.J. Bidirectional selective breeding for ethanol effects on locomotor activity: characterization of FAST and SLOW mice through selection generation 35. Alcoholism: Clinical and Experimental Research 19 (1995) 1234-1245
252. Shin D.M., Korada S., Raballo R., Shashikant C.S., Simeone A., Taylor J.R., and Vaccarino F. Loss of glutamatergic pyramidal neurons in frontal and temporal cortex resulting from attenuation of FGFR1 signaling is associated with spontaneous hyperactivity in mice. Journal of Neuroscience 24 (2004) 2247-2258
253. Sieber B.A., Kuzmin A., Canals J.M., Danielsson A., Paratcha G., Arenas E., Alberch J., Ogren S.O., and Ibanez C.F. Disruption of EphA/ephrin-a signaling in the nigrostriatal system reduces dopaminergic innervation and dissociates behavioral responses to amphetamine and cocaine. Molecular and Cellular Neuroscience 26 (2004) 418-428
254. Siesser W.B., Cheng S.Y., and McDonald M.P. Hyperactivity, impaired learning on a vigilance task, and a differential response to methylphenidate in the TRbetaPV knock-in mouse. Psychopharmacology (Berlin) 181 (2005) 653-663
255. Siesser W.B., Zhao J., Miller L.R., Cheng S.Y., and McDonald M.P. Transgenic mice expressing a human mutant beta1 thyroid receptor are hyperactive, impulsive, and inattentive. Genes, Brain and Behavior 5 (2006) 282-297
256. Siuciak J.A., McCarthy S.A., Chapin D.S., Fujiwara R.A., James L.C., Williams R.D., Stock J.L., McNeish J.D., Strick C.A., Menniti F.S., and Schmidt C.J. Genetic deletion of the striatum-enriched phosphodiesterase PDE10A: evidence for altered striatal function. Neuropharmacology 51 (2006) 374-385
257. Skelton M.R., Ponniah S., Wang D.Z., Doetschman T., Vorhees C.V., and Pallen C.J. Protein tyrosine phosphatase alpha (PTP alpha) knockout mice show deficits in Morris water maze learning, decreased locomotor activity, and decreases in anxiety. Brain Research 984 (2003) 1-10
258. Smith D.G., Tzavara E.T., Shaw J., Luecke S., Wade M., Davis R., Salhoff C., Nomikos G.G., and Gehlert D.R. Mesolimbic dopamine super-sensitivity in melanin-concentrating hormone-1 receptor-deficient mice. Journal of Neuroscience 25 (2005) 914-922
259. Soderpalm B., Ericson M., Bohlooly M., Engel J.A., and Tornell J. Bovine growth hormone transgenic mice display alterations in locomotor activity and brain monoamine neurochemistry. Endocrinology 140 (1999) 5619-5625
260. Sora I., Wichems C., Takahashi N., Li X.F., Zeng Z., Revay R., Lesch K.P., Murphy D.L., and Uhl G.R. Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice. Proceedings of the National Academy of Sciences of the United States of America 95 (1998) 7699-7704
261. Spielewoy C., Biala G., Roubert C., Hamon M., Betancur C., and Giros B. Hypolocomotor effects of acute and daily d-amphetamine in mice lacking the dopamine transporter. Psychopharmacology (Berlin) 159 (2001) 2-9
262. Starke K. Presynaptic autoreceptors in the third decade: focus on alpha2-adrenoceptors. Journal of Neurochemistry 78 (2001) 685-693
263. Steckler T., and Holsboer F. Conditioned activity to amphetamine in transgenic mice expressing an antisense RNA against the glucocorticoid receptor. Behavior and Neuroscience 115 (2001) 207-219
264. Stone E.A., Zhang Y., Rosengarten H., Yeretsian J., and Quartermain D. Brain alpha 1-adrenergic neurotransmission is necessary for behavioral activation to environmental change in mice. Neuroscience 94 (1999) 1245-1252
265. Sulzer D., and Rayport S. Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action. Neuron 5 (1990) 797-808
266. Sulzer D., Chen T.K., Lau Y.Y., Kristensen H., Rayport S., and Ewing A. Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. Journal of Neuroscience 15 (1995) 4102-4108
267. Sulzer D., Sonders M.S., Poulsen N.W., and Galli A. Mechanisms of neurotransmitter release by amphetamines: a review. Progress in Neurobiology 75 (2005) 406-433
268. Svenningsson P., Tzavara E.T., Carruthers R., Rachleff I., Wattler S., Nehls M., McKinzie D.L., Fienberg A.A., Nomikos G.G., and Greengard P. Diverse psychotomimetics act through a common signaling pathway. Science 302 (2003) 1412-1415
269. Swanson J.M., Sergeant J.A., Taylor E., Sonuga-Barke E.J., Jensen P.S., and Cantwell D.P. Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet 351 (1998) 429-433
270. Szumlinski K.K., Dehoff M.H., Kang S.H., Frys K.A., Lominac K.D., Klugmann M., Rohrer J., Griffin III W., Toda S., Champtiaux N.P., Berry T., Tu J.C., Shealy S.E., During M.J., Middaugh L.D., Worley P.F., and Kalivas P.W. Homer proteins regulate sensitivity to cocaine. Neuron 43 (2004) 401-413
271. Szumlinski K.K., Lominac K.D., Kleschen M.J., Oleson E.B., Dehoff M.H., Schwarz M.K., Seeburg P.H., Worley P.F., and Kalivas P.W. Behavioral and neurochemical phenotyping of Homer1 mutant mice: possible relevance to schizophrenia. Genes, Brain and Behavior 4 (2005) 273-288
272. Takahashi N., Miner L.L., Sora I., Ujike H., Revay R.S., Kostic V., Jackson-Lewis V., Przedborski S., and Uhl G.R. VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity. Proceedings of the National Academy of Sciences of the United States of America 94 (1997) 9938-9943
273. Takeda K., Weiss R.E., and Refetoff S. Rapid localization of mutations in the thyroid hormone receptor-beta gene by denaturing gradient gel electrophoresis in 18 families with thyroid hormone resistance. Journal of Clinical Endocrinology and Metabolism 74 (1992) 712-719
274. Tanaka K., Shintani N., Hashimoto H., Kawagishi N., Ago Y., Matsuda T., Hashimoto R., Kunugi H., Yamamoto A., Kawaguchi C., Shimada T., and Baba A. Psychostimulant-induced attenuation of hyperactivity and prepulse inhibition deficits in Adcyap1-deficient mice. Journal of Neuroscience 26 (2006) 5091-5097
275. Tancer M., and Johanson C.E. The effects of fluoxetine on the subjective and physiological effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology (Berlin) 189 (2007) 565-573
276. Tappe A., and Kuner R. Regulation of motor performance and striatal function by synaptic scaffolding proteins of the Homer1 family. Proceedings of the National Academy of Sciences of the United States of America 103 (2006) 774-779
277. Torkamanzehi A., Boksa P., Ayoubi M., Fortier M.E., Ng Ying Kin N.M., Skamene E., Rouleau G., and Joober R. Identification of informative strains and provisional QTL mapping of amphetamine (AMPH)-induced locomotion in recombinant congenic strains (RCS) of mice. Behavior Genetics 36 (2006) 903-913
278. Toyota H., Dugovic C., Koehl M., Laposky A.D., Weber C., Ngo K., Wu Y., Lee D.H., Yanai K., Sakurai E., Watanabe T., Liu C., Chen J., Barbier A.J., Turek F.W., Fung-Leung W.P., and Lovenberg T.W. Behavioral characterization of mice lacking histamine H(3) receptors. Molecular Pharmacology 62 (2002) 389-397
279. Tsai G., Ralph-Williams R.J., Martina M., Bergeron R., Berger-Sweeney J., Dunham K.S., Jiang Z., Caine S.B., and Coyle J.T. Gene knockout of glycine transporter 1: characterization of the behavioral phenotype. Proceedings of the National Academy of Sciences of the United States of America 101 (2004) 8485-8490
280. Ujike H., and Sato M. Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis. Annals of the New York Academy of Sciences 1025 (2004) 279-287
281. Ujike H., Harano M., Inada T., Yamada M., Komiyama T., Sekine Y., Sora I., Iyo M., Katsu T., Nomura A., Nakata K., and Ozaki N. Nine- or fewer repeat alleles in VNTR polymorphism of the dopamine transporter gene is a strong risk factor for prolonged methamphetamine psychosis. Pharmacogenomics Journal 3 (2003) 242-247
282. Umemori H., Ogura H., Tozawa N., Mikoshiba K., Nishizumi H., and Yamamoto T. Impairment of N-methyl-D-aspartate receptor-controlled motor activity in LYN-deficient mice. Neuroscience 118 (2003) 709-713
283. van den Buuse M., Simpson E.R., and Jones M.E. Prepulse inhibition of acoustic startle in aromatase knock-out mice: effects of age and gender. Genes, Brain and Behavior 2 (2003) 93-102
284. van den Buuse M., Martin S., Brosda J., Leck K.J., Matthaei K.I., and Hendry I. Enhanced effect of dopaminergic stimulation on prepulse inhibition in mice deficient in the alpha subunit of G(z). Psychopharmacology (Berlin) 183 (2005) 358-367
285. van den Buuse M., van Driel I.R., Samuelson L.C., Pijnappel M., and Martin S. Reduced effects of amphetamine on prepulse inhibition of startle in gastrin-deficient mice. Neuroscience Letters 373 (2005) 237-242
286. van der Meulen E.M., Bakker S.C., Pauls D.L., Oteman N., Kruitwagen C.L., Pearson P.L., Sinke R.J., and Buitelaar J.K. High sibling correlation on methylphenidate response but no association with DAT1-10R homozygosity in Dutch sibpairs with ADHD. Journal of Child Psychology and Psychiatry 46 (2005) 1074-1080
287. Vanderschuren L.J., Schmidt E.D., De Vries T.J., Van Moorsel C.A., Tilders F.J., and Schoffelmeer A.N. A single exposure to amphetamine is sufficient to induce long-term behavioral, neuroendocrine, and neurochemical sensitization in rats. Journal of Neuroscience 19 (1999) 9579-9586
288. Vasar E., Harro J., Lang A., Pold A., and Soosaar A. Differential involvement of CCK-A and CCK-B receptors in the regulation of locomotor activity in the mouse. Psychopharmacology (Berlin) 105 (1991) 393-399
289. Veenstra-VanderWeele J., Qaadir A., Palmer A.A., Cook Jr. E.H., and de Wit H. Association between the casein kinase 1 epsilon gene region and subjective response to D-amphetamine. Neuropsychopharmacology 31 (2006) 1056-1063
290. Ventura R., Pascucci T., Catania M.V., Musumeci S.A., and Puglisi-Allegra S. Object recognition impairment in Fmr1 knockout mice is reversed by amphetamine: involvement of dopamine in the medial prefrontal cortex. Behavioural Pharmacology 15 (2004) 433-442
291. Volkow N.D., Chang L., Wang G.J., Fowler J.S., Ding Y.S., Sedler M., Logan J., Franceschi D., Gatley J., Hitzemann R., Gifford A., Wong C., and Pappas N. Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. American Journal of Psychiatry 158 (2001) 2015-2021
292. Wang G.J., Volkow N.D., Chang L., Miller E., Sedler M., Hitzemann R., Zhu W., Logan J., Ma Y., and Fowler J.S. Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence. American Journal of Psychiatry 161 (2004) 242-248
293. Wang J.H., Short J., Ledent C., Lawrence A.J., and van den Buuse M. Reduced startle habituation and prepulse inhibition in mice lacking the adenosine A2A receptor. Behavioural Brain Research 143 (2003) 201-207
294. Wang Y.M., Gainetdinov R.R., Fumagalli F., Xu F., Jones S.R., Bock C.B., Miller G.W., Wightman R.M., and Caron M.G. Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine. Neuron 19 (1997) 1285-1296
295. Weinshenker D., Miller N.S., Blizinsky K., Laughlin M.L., and Palmiter R.D. Mice with chronic norepinephrine deficiency resemble amphetamine-sensitized animals. Proceedings of the National Academy of Sciences of the United States of America 99 (2002) 13873-13877
296. Wenger G.R. The role of control activity levels in the reported strain differences to the behavioral effects of drugs in mice. Pharmacology, Biochemistry and Behavior 32 (1989) 241-247
297. Willis-Owen S.A., and Flint J. Identifying the genetic determinants of emotionality in humans; insights from rodents. Neuroscience and Biobehavioral Reviews 31 (2007) 115-124
298. Wimer R.E. Some uses of inbred strains. In: Goldowitz D., Wahlsten D., and Wimer R.E. (Eds). Techniques for the Genetic Analysis of Brain and Behavior: Focus on the Mouse (1992), Elsevier, Amsterdam 57-66
299. Winsberg B.G., and Comings D.E. Association of the dopamine transporter gene (DAT1) with poor methylphenidate response. Journal of the American Academy of Child and Adolescent Psychiatry 38 (1999) 1474-1477
300. Wolinsky T.D., Swanson C.J., Smith K.E., Zhong H., Borowsky B., Seeman P., Branchek T., and Gerald C.P. The Trace Amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia. Genes, Brain and Behavior 6 (2007) 628-639
301. Wu R., and Lin M. Functional mapping-how to map and study the genetic architecture of dynamic complex traits. Nature Reviews Genetics 7 (2006) 229-237
302. Wunderlich G.R., DeSousa N.J., and Vaccarino F.J. Cholecystokinin modulates both the development and the expression of behavioral sensitization to amphetamine in the rat. Psychopharmacology (Berlin) 151 (2000) 283-290
303. Xu M., Koeltzow T.E., Santiago G.T., Moratalla R., Cooper D.C., Hu X.T., White N.M., Graybiel A.M., White F.J., and Tonegawa S. Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors. Neuron 19 (1997) 837-848
304. Xu F., Gainetdinov R.R., Wetsel W.C., Jones S.R., Bohn L.M., Miller G.W., Wang Y.M., and Caron M.G. Mice lacking the norepinephrine transporter are supersensitive to psychostimulants. Nature Neuroscience 3 (2000) 465-471
305. Xu M., Guo Y., Vorhees C.V., and Zhang J. Behavioral responses to cocaine and amphetamine administration in mice lacking the dopamine D1 receptor. Brain Research 852 (2000) 198-207
306. Xu R., Hranilovic D., Fetsko L.A., Bucan M., and Wang Y. Dopamine D2S and D2L receptors may differentially contribute to the actions of antipsychotic and psychotic agents in mice. Molecular Psychiatry 7 (2002) 1075-1082
307. Yamashita M., Fukushima S., Shen H.W., Hall F.S., Uhl G.R., Numachi Y., Kobayashi H., and Sora I. Norepinephrine transporter blockade can normalize the prepulse inhibition deficits found in dopamine transporter knockout mice. Neuropsychopharmacology 31 (2006) 2132-2139
308. Yan Y., Nitta A., Mizoguchi H., Yamada K., and Nabeshima T. Relapse of methamphetamine-seeking behavior in C57BL/6J mice demonstrated by a reinstatement procedure involving intravenous self-administration. Behavioural Brain Research 168 (2006) 137-143
309. Yee B.K., Keist R., von Boehmer L., Studer R., Benke D., Hagenbuch N., Dong Y., Malenka R.C., Fritschy J.M., Bluethmann H., Feldon J., Mohler H., and Rudolph U. A schizophrenia-related sensorimotor deficit links alpha 3-containing GABAA receptors to a dopamine hyperfunction. Proceedings of the National Academy of Sciences of the United States of America 102 (2005) 17154-17159
310. Yuan J., Hatzidimitriou G., Suthar P., Mueller M., McCann U., and Ricaurte G. Relationship between temperature, dopaminergic neurotoxicity, and plasma drug concentrations in methamphetamine-treated squirrel monkeys. Journal of Pharmacology and Experimental Therapeutics 316 (2006) 1210-1218
311. Zeni C.P., Guimaraes A.P., Polanczyk G.V., Genro J.P., Roman T., Hutz M.H., and Rohde L.A. No significant association between response to methylphenidate and genes of the dopaminergic and serotonergic systems in a sample of Brazilian children with attention-deficit/hyperactivity disorder. American Journal of Medical Genetics B: Neuropsychiatric Genetics 144 (2007) 391-394
312. Zhang Y., Loonam T.M., Noailles P.A., and Angulo J.A. Comparison of cocaine- and methamphetamine-evoked dopamine and glutamate overflow in somatodendritic and terminal field regions of the rat brain during acute, chronic, and early withdrawal conditions. Annals of the New York Academy of Sciences 937 (2001) 93-120
313. Zhuang X., Oosting R.S., Jones S.R., Gainetdinov R.R., Miller G.W., Caron M.G., and Hen R. Hyperactivity and impaired response habituation in hyperdopaminergic mice. Proceedings of the National Academy of Sciences of the United States of America 98 (2001) 1982-1987
314. Zocchi A., Orsini C., Cabib S., and Puglisi-Allegra S. Parallel strain-dependent effect of amphetamine on locomotor activity and dopamine release in the nucleus accumbens: an in vivo study in mice. Neuroscience 82 (1998) 521-528